New Publication: MADRAC Bulletin - Issue 2/2017

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

MADRAC Bulletin - Issue 02/2017

 

Regulatory Matters

▪ Chlorhexidine preparations: Risk of hypersensitivity reactions
▪ Miconazole & Warfarin: Risk of severe bleeding as a result of drug interaction
▪ Inhaled Corticosteroids: Increased risk of pneumonia in Chronic Obstructive Pulmonary Disease (COPD) patients
▪ Etoricoxib: New dosing for rheumatoid arthritis and ankylosing spondylitis

What’s New

▪ Annie & Mac’s Adventures: Pharmacovigilance Comic Book Pilot Survey

▪ Pharmacovigilance Inspection Training at the UK MHRA


 

drgd 
  DOWNLOAD PDF


National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Tuesday 13 November 2018, 11:21:38.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA